Enovis delivered a strong first quarter in 2025 with revenues and margins exceeding expectations, driven by continued commercial momentum and growth in both Prevention & Recovery and Reconstructive segments.
First-quarter net sales grew 8% on a reported basis and 9% on a comparable basis year-over-year.
Adjusted EBITDA was $99 million, or 17.7% of sales, a 160 basis point increase from the prior-year quarter.
Net loss from continuing operations was $56 million, or $0.98 per share.
Adjusted net earnings per diluted share were $0.81.
Enovis updated its full-year 2025 financial expectations, raising revenue guidance but lowering adjusted EBITDA and adjusted EPS forecasts.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance